LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Disease-Related Epigenetic Variations Summarized in New DNA Methylation Atlas

By LabMedica International staff writers
Posted on 10 Jun 2019
Image: A representation of a methylated DNA molecule. The two white spheres represent methyl groups bound to two cytosine nucleotide molecules (Photo courtesy of Wikimedia Commons).
Image: A representation of a methylated DNA molecule. The two white spheres represent methyl groups bound to two cytosine nucleotide molecules (Photo courtesy of Wikimedia Commons).
A new DNA methylation atlas summarized a previously unexplored molecular level of human individuality called correlated regions of systemic interindividual variation (CoRSIVs), which may provide a resource for future population-based investigations into how interindividual epigenetic variation modulates risk of disease.

DNA methylation is an important determinant of human phenotypic variation, but its inherent cell type specificity has impeded progress on this question. At exceptional genomic regions, variation in DNA methylation between individuals occurs systemically. Like genetic variants, these systemic "interindividual" epigenetic variants are stable, can influence phenotype, and can be assessed in any easily obtained DNA sample.

Previous studies identified systemic interindividual variation (SIV) in DNA methylation by genome-scale DNA methylation profiling in multiple tissues from multiple individuals but were limited by the profiling technique and/or the number of tissues and individuals studied.

For the current study, investigators at Baylor College of Medicine (Houston, TX, USA) and Texas Children's Hospital (Houston, USA) used deep whole-genome bisulfite sequencing to measure genomic DNA CpG methylation from tissues representing the three germ layer lineages: thyroid (endoderm), heart (mesoderm), and brain (ectoderm) in samples taken from 10 donors from the NIH Genotype-Tissue Expression (GTEx) program.

The investigators developed a computational algorithm to identify genomic regions at which interindividual variation in DNA methylation was consistent across all three lineages. This approach identified 9926 correlated regions of CoRSIVs. These regions, comprising just 0.1% of the human genome, were inter-correlated over long genomic distances and were associated with genes implicated in a broad range of human disorders and phenotypes. Thus, CoRSIV methylation in one tissue could predict expression of associated genes in other tissues.

"Since these tissues each represent a different layer of the early embryo, we are essentially going back in time to events that occurred during early embryonic development," said senior author Dr. Robert A. Waterland, professor of molecular and human genetics at Baylor College of Medicine. "To map DNA methylation we converted methylation information into a genetic signal, then sequenced the genomes. Because epigenetic marking has the power to stably silence or stably activate genes, any disease that has a genetic basis could equally likely have an epigenetic basis. There is incredible potential for us to understand disease processes from an epigenetic perspective. CoRSIVs are the entryway to that."

The study was published in the June 3, 2019, online edition of the journal Genome Biology.

Related Links:
Baylor College of Medicine
Texas Children's Hospital

Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Alcohol Testing Device
Dräger Alcotest 7000
Laboratory Software
ArtelWare

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more